Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Prepaid Assets (2020 - 2026)

Invivyd's (IVVD) quarterly Prepaid Assets came in at $10.8 million in Q2 2026, down 31.05% on a YoY basis from $15.7 million in Q2 2025, and up 57.6% quarter-over-quarter from $6.9 million in Q4 2025.

Analysis

Invivyd (IVVD) Prepaid Assets (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Prepaid Assets for 7 consecutive years, with $10.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 31.05% year-over-year to $10.8 million; the trailing twelve-month figure through Jun 2026 stood at $10.8 million (down 31.05% YoY), and the FY2025 full-year result was $6.9 million, down 66.42% from the prior year.
  • Prepaid Assets improved to $10.8 million in Q2 2026 per IVVD's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $24.2 million in Q4 2023 and bottomed at $2.9 million in Q3 2022.
  • Historically, Prepaid Assets has averaged $13.1 million across 5 years, with a median of $11.6 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Prepaid Assets sank 80.52% in 2022, then surged 392.08% in 2023.
  • Over 5 years, Prepaid Assets stood at $4.9 million in 2022, then soared by 392.08% to $24.2 million in 2023, then slipped by 15.73% to $20.4 million in 2024, then plunged by 66.42% to $6.9 million in 2025, then jumped by 57.6% to $10.8 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $10.8 million, $6.9 million, and $15.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.81 Mn
Dec 31, 2025 6.86 Mn
Sep 30, 2025 14.95 Mn
Jun 30, 2025 15.68 Mn
Mar 31, 2025 19.19 Mn
Dec 31, 2024 20.43 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 16.91 Mn
Mar 31, 2024 20.39 Mn
Dec 31, 2023 24.24 Mn
Sep 30, 2023 5.22 Mn
Jun 30, 2023 11.56 Mn
Mar 31, 2023 11.20 Mn
Dec 31, 2022 4.93 Mn
Sep 30, 2022 2.93 Mn
Jun 30, 2022 6.48 Mn
Mar 31, 2022 22.08 Mn
Dec 31, 2021 25.29 Mn
Sep 30, 2021 13.83 Mn
Jun 30, 2021 3.55 Mn